Profarma Distribuidora de Produtos Farmacêuticos S.A. (BOVESPA: PFRM3)
Health Care · Health Care Providers & Services · BR
R$7.08
-1.39% today · -9.9% 1Y
Profarma Distribuidora de Produtos Farmacêuticos S.A. (BOVESPA: PFRM3) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $168.23M and employs 7,077 people.
Over the last twelve months the share price has lost 9.9%, trading between 6.11 and 9.70.
Tweenvest scores Profarma Distribuidora de Produtos Farmacêuticos S.A. across four factors: quality 67/100, value 77/100, growth 71/100, dividend 90/100. Its strongest factor is dividend.
PFRM3 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $168.23M
- Revenue (TTM)
- $2.41B
- P/E
- 5.62
- EPS
- 1.26
- Dividend yield
- 8.12%
- Beta (5Y)
- 0.33
- 52-week high
- R$9.70
- 52-week low
- R$6.11
- Avg volume (3M)
- —
- Shares outstanding
- 122.61M
- Employees
- 7,077
- Next earnings
- —
About Profarma Distribuidora de Produtos Farmacêuticos S.A.
Established in 1961 and headquartered in Rio de Janeiro, Brazil, Profarma Distribuidora de Produtos Farmacêuticos S.A. is a prominent player in the Brazilian healthcare market, focusing on both the wholesale and retail sales of pharmaceutical and hospital supplies. The company's operations are divided into distinct Distribution and Retail segments. Its comprehensive product offerings include a vast array of pharmaceuticals, such as brand-name drugs, generic alternatives, and over-the-counter medications. Profarma also supplies essential hospital products, including injectable and infusion therapies for specialized medical areas like oncology, endocrinology, rheumatology, infectology, and hematology. Furthermore, it provides specific treatments such as vaccines for conditions like influenza, HPV, meningitis, hepatitis, chickenpox, and dengue, alongside specialized medicines for rare and complex diseases. Beyond pharmaceuticals, the company distributes a wide selection of personal care, beauty, and cosmetic items. This category encompasses shampoos, conditioners, treatment creams, hair dyes, baby products like diapers, soaps, deodorants, oral care essentials, sunscreens, men's grooming products, cosmetics, makeup, and skincare. Profarma also features proprietary lines under the Nº21, GOnutri, and Bem Básico brands, offering exclusive hygiene and beauty products, vitamins, and workshop items. Complementing these, convenience goods such as food products, blood pressure monitors, and scales are also available. The company extends its services to include promotional and logistical support, implementation of marketing campaigns, product recall management, development of bespoke solutions for laboratories, and oversight of clinical procedures. As of December 31, 2019, Profarma's infrastructure boasted eleven strategically located distribution centers across several Brazilian states (Alagoas, Bahia, Espírito Santo, Goiás, Minas Gerais, Paraíba, Paraná, Pernambuco, Rio Grande do Sul, Rio de Janeiro, and São Paulo). Its retail footprint comprised approximately 196 stores operating under the Drogarias Tamoio, Drogasmil, Farmalife, and Rede Rosário banners, situated in the states of Rio de Janeiro, Goiás, Tocantins, Mato Grosso, and Distrito Federal.
- ISIN
- BRPFRMACNOR1
- Founded
- 1961
- Listed since
- Oct 26, 2006
- Exchange
- Bolsa de Valores de Sao Paulo
- Currency
- BRL
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $350.16B | $390.11 | +1.37% |
| CVS Health CorporationNYSE: CVS | $118.97B | $93.02 | -0.67% |
| McKesson CorporationNYSE: MCK | $100.14B | $858.90 | +2.40% |
| HCA Healthcare, Inc.NYSE: HCA | $92.92B | $429.19 | +5.64% |
| Elevance Health, Inc.NYSE: ELV | $86.86B | $400.54 | +1.07% |
| The Cigna GroupNYSE: CI | $73.33B | $277.51 | +1.13% |
| Cencora, Inc.NYSE: COR | $60.69B | $318.04 | +1.06% |
| Cardinal Health, Inc.NYSE: CAH | $53.38B | $229.51 | +0.46% |
Figures last refreshed Aug 18, 2026.